Benjamin Tomlinson
Clinical trials sponsored by Benjamin Tomlinson, explained in plain language.
-
New gentle chemo combo after transplant aims to stop leukemia relapse
Disease control Recruiting nowThis study tests whether a low-dose, weekly chemotherapy combination (decitabine and venetoclax) given after a bone marrow transplant can help prevent high-risk myeloid cancers like acute myeloid leukemia from coming back. About 20 participants will receive the treatment for up t…
Phase: PHASE1, PHASE2 • Sponsor: Benjamin Tomlinson • Aim: Disease control
Last updated Jun 16, 2026 12:51 UTC
-
New Low-Dose combo aims to outsmart drug resistance in bone marrow disease
Disease control Recruiting nowThis study tests a new way of giving two approved drugs (5-azacitidine and decitabine) to people with myelodysplastic syndromes (MDS) or related bone marrow disorders. Instead of standard high doses, the drugs are given in a low-dose, alternating schedule to reduce side effects a…
Phase: EARLY_PHASE1 • Sponsor: Benjamin Tomlinson • Aim: Disease control
Last updated Jun 09, 2026 12:07 UTC